Raising Finance
Once a company reaches a stage of maturity at which significant financial assistance is required to reach the next phase of technology commercialisation, such as clinical trials, prototype testing or scale-up manufacturing, institutional investment is usually sought. This predominantly takes the form of angel investors, bank loans or venture capital investors.
Venture capital investors are dedicated to creating or growing companies that will develop and market products and services that meet unmet market needs.
VCs expect investee companies to:
- Have outstanding management teams
- Own key intellectual property and know how
- Have a pipeline of potential products
- Have the potential to achieve an IPO or trade sale within 3-5 years at a valuation in excess of 10 times their invested capital
- Generate revenues that minimise equity capital requirements
- Develop technology platforms that generate multiple products
- Have projected/potential markets in excess of $100 million
Bio Innovation SA Capabilities
Bio Innovation SA can help you prepare your company to seek institutional venture capital investment to fund the next stage in your company’s growth. Bio Innovation SA can help you refine your marketing documents and pitch and can help you select which venture investors to approach and how to value your company.
Links
Australia New Zealand Biotechnology Partnership Fund |
|
Australian Venture Capital Association (AVCAL) |
|
BioAngels Inc |
|
CM Capital |
|
| GBS Venture Partners |
|
Innovation Capital |
|
Queensland BioCapital Funds (QBF) |
|
Starfish |
|
Start-up Australia |
|
Terra Rossa Capital (TRC) |
|
Trans Tasman Commercialisation Fund |
|
Venture Capital Journal |
|
Venture Capital SA |
[Return to the Business Development Page]
Bio Innovation SA
Level 15/33
King William Street
Adelaide SA 5000
Australia
Phone:61 8 8217 6400
Fax:61 8 8217 6416
Bioscience Achievement Awards Announced
3 March 2010 - The 2010 BioSA Bioscience Achievement Awards have today recognised two women for their outstanding contributions to the bioscience sector in South Australia. (read more...)
Adelaide research impact brings national awards
3 March 2010 - University of Adelaide researchers have won two of the five categories in the inaugural Scopus Young Researcher of the Year Awards, to be presented tonight by Senator Kim Carr. (read more...)
BNC210 Clinical Trial Results Confirm Safety and Indicate Reduced Stress Hormone Levels
2 March 2010 - Bionomics Limited (ASX: BNO) today announced the final results of its Phase Ia clinical trial of BNC210. (read more...)
Agricultural revolution needed for 21st century
12 February 2010 - Substantial changes in agriculture will be needed to feed an estimated nine billion people living on the planet by 2050, according to a paper published today in Science by two University of Adelaide researchers. (read more...)
BioSA Networking Forum & Presentations
FLINDERS IN THE CITY
Date: Thursday, 29 April 2010
Time: Presentations from 5.30pm followed by networking to 8.30pm
Venue: 182 Victoria Square, Adelaide. (Old Reserve Bank Building)
(read more...)
Australasian Association of Bioethics and Health Law
1-4 July 2010 - The University of Adelaide (read more...)
LESANZ Annual Conference 2010
22-24 April 2010, InterContinental Hotel, Adelaide (read more...)
